Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
HT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.90NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.18.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.26.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FK.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.76NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.6.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.40NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.60NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.49NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.9.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDK.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KT.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.49.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.3.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used